Trimetazidine in patients with valvular heart disease who have undergone valve replacement

Trial Profile

Trimetazidine in patients with valvular heart disease who have undergone valve replacement

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Oct 2013

At a glance

  • Drugs Trimetazidine (Primary)
  • Indications Heart failure; Left ventricular dysfunction; Valvular heart disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2013 New trial record
    • 04 Sep 2013 Efficacy and tolerability results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
    • 04 Sep 2013 Quality-of-life results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top